Internal Funding Opportunities
The Utah Center for Clinical and Translational Science (CCTS) offers a variety of funding and program opportunities to advance the research community.
CCTS Pilot Project Award
Pilot projects will exemplify the CCTS mission of developing clinical and translational research, to promote and support the “bench to bedside to community and practice and back” goal of the NIH. The purpose of this research announcement is to support pilot projects that utilize the CCTS infrastructure to produce preliminary data for competitive NIH grant proposals in clinical and translational (T1, T2, T3, and T4) research. Projects must be of high methodological quality and must demonstrate feasible and generalizable solutions to translational research problems.
Applications are being accepted at this time via: Competition Space
CCTS/Program in Personalized Health (PPH) Pilot Project Award
The CCTS/PPH Pilot Projects supports multidisciplinary investigators in conducting education, research, or clinical work aimed at introducing and improving methodologies for individualized patient care in Utah. The purpose of this research announcement is to support pilot projects that utilize the CCTS infrastructure to produce preliminary data for competitive NIH grant proposals in clinical and translational (T1, T2, T3, and T4) personalized health research. Projects must be of high methodological quality and must demonstrate feasible and generalizable solutions to translational research problems.
Applications are not being accepted at this time. For information on the next cycle, please contact Linda Galbreath.
The Clinical and Translational Science Awards (CTSA) of University of Utah (UU), University of New Mexico Health Sciences Center (UNM HSC), University of Kansas Medical Center (KUMC), University of Arkansas for Medical Sciences (UAMS), and the University of Kentucky (KU) are soliciting applications from all faculty members—senior as well as junior investigators—for pilot projects that will exemplify the CTSA mission of developing clinical and translational research, to promote and support the “bench to bedside to community and practice and back” goal of the NIH. The purpose of this funding announcement is to promote inter‐institutional collaboration across the CTSA consortium by funding innovative, translational research projects that involve two or more of these four CTSA institutions.
Co-directed by Drs. Maureen Murtaugh and David Turok, the CCTS KL2 is supported by the Utah CCTS, Primary Children’s Hospital Foundation (Intermountain Healthcare), and Utah Department of Health. The overall goal is to foster translational research on clinically relevant questions enabling basic science findings to be more rapidly applied to clinical problems. The competitive training program offers mentored research and career development support for clinical junior investigators conducting innovative research for one or two years, based on available funding.
Scholars commit to a minimum of 75 percent protected time for research and training and are encouraged and provided resources to seek independent grant research support during the award period. Each scholar participates in the University of Utah Vice President’s Clinical & Translational (VPCAT) Research Scholars program that includes didactic education, mentored research, interdisciplinary works-in-progress seminars, and team-building experiences. A structured curriculum has been designed to provide leadership competencies and develop the essential research knowledge and practical skills to be an effective clinical or translational researcher. They are provided a mentoring team consisting of a scientific mentor, a VPCAT senior mentor, peer mentors, and staff mentors support.
The KL2 Mentored Career Development Scholar program co-directors meet with scholars quarterly to oversee the mentorship of the scholar to assure progress. Each scholar creates and completes an individual development program tailored to their research and career development needs. Scholars have access to biostatisticians in the CCTS Population Health Research group, and the KL2 Program Manager provides grant submission support. These resources facilitate appropriate study design, collection of pilot data, and the preparation and submission of competitive grant applications. Learn more.
The Utah Center for Clinical and Translational Science (CCTS) offers the TL1 postdoctoral training in Human Genome Analysis Program to MD, MD/PhD, and PhD postdoctoral investigators to integrate genomics with biological and clinical research, a great strength of the University of Utah. Led by Drs. Lynn B. Jorde and Mark Yandell, the program aims to develop the research skills of fellows who will work in all aspects of the gene discovery enterprise and empower them to cross the bridge between the clinic and genetics laboratory, identifying kindreds with familial disorders, analyzing sequence data, and identifying disease-causing genes. Find more information.
The MSCI Program is a vital component of the University of Utah CCTS and provides classroom and mentored research experience in clinical research, preparing its trainees for careers in clinical investigation, both in academic medicine and the allied health sciences. Students in good standing in the MS in Clinical Investigation may apply for partial tuition scholarships for fall and spring semesters. The amount of the scholarship to each student receiving an award will be between $250 and $1,000 per semester. The amount of the scholarship and number of scholarships each semester will vary depending on the availability of funds. Students must reapply for each semester. Learn more.
CCTS Peer Grant Review Program
The Utah CCTS accepts research strategy/plan narratives for pre-submission peer review. Rigorous grant review prior to the submission of an application to a funding agency is an essential component of successful applications. The goal of the pre-submission peer review is to provide useful feedback regarding the strengths and weaknesses of the research narrative in order to aid the investigator in submitting the strongest application possible. Each research narrative will receive a thorough and impartial review by at least one reviewer. Each narrative will be scored independently using the NIH review criteria. Investigators will be provided reviews within 30 days after submission, allowing for adequate time to incorporate reviewer comments into their final agency submission. All health sciences faculty submitting grant applications are eligible to submit their research narratives for review.